Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Wacker, Recipharm, and ApiJect. Biologics Manufacturing CureVac, Wacker in Mfg Pact for COVID-19 VaccineCureVac, a Tubingen, Germany-based clinical-stage biopharmaceutical...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Almac, Samsung Biologics, and Cytiva. Chemicals/Chemical API Manufacturing Almac Gets $500,000 Grant for Mfg of COVID-19 Drug RemdesivirAlmac Sciences, a member of the Almac...

Cambrex has announced plans to invest more than $50 million to expand its mid-scale and large-scale active pharmaceutical ingredient (API) manufacturing capacity at its site in Charles City, Iowa. The expansion, which will be operational in early...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Lonza and Eurofins. Biologics Manufacturing Lonza, Altimmune in Mfg Pact for Intranasal COVID-19 Vaccine Lonza and Altimmune, a Gaithersburg, Maryland-based clinical-stage...

Vibalogics, a CDMO of oncolytic viruses, viral vector vaccines, and viral vectors, has initiated Phase I of a $150-million investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, Massachusetts. The...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Flamma, Lonza, MilliporeSigma, and Grand River Aseptic Manufacturing. Chemicals/Chemical API Manufacturing Flamma in Mfg Pact for Gilead’s COVID-19 Drug RemdesivirFlamma SpA,...

Pierre-Alain Ruffieux, formerly Head of Global Pharma Technical Operations at Roche, has joined Lonza Group as its new Chief Executive Officer (CEO). Lonza had named him as the company’s new CEO in June. He succeeds Albert Baehny, Chairman of...

The latest from CDMOs, CMOs, and suppliers featuring Catalent, Samsung Biologics, AGC Biologics, Aphena Pharma Solutions, Sai Life Sciences, and others. Chemicals/Chemical API Manufacturing Charkit, Elé Corporation in Distribution PactCharkit...

Lonza is investing CHF 85 million ($94 million) in its Capsules and Health Ingredients (CHI) Division to expand its overall capsule production capacity by 30 billion capsules annually across eight sites. The investment will allow a 15% increase in...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Evotec, Samsung Biologics, and Thermo Fisher Scientific. Biologics Manufacturing Evotec Gets Grant from Gates Foundation for COVID-19 mAbsJust–Evotec Biologics, a technology...

The latest from CDMOs, CMOs, and suppliers featuring CordenPharma, MilliporeSigma, Vetter, Catalent, JSR Life Sciences, Incog BioPharma, Brand-Nu Laboratories and Cadlic. Chemicals/Chemical API Manufacturing CordenPharma Completes Highly Potent...